| Financial Year |
March 31 2023 |
| Monetary Funds |
659,916,268.29 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
162,231,751.13 |
| Accounts Receivable |
909,098,839.99 |
| Advances to Suppliers |
46,644,446.25 |
| Other Receivables |
54,421,837.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
691,609,672.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,605,021.89 |
| Total Current Assets |
2,643,726,374.42 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
21,883,828.53 |
| Investment Properties |
-- |
| Fixed Assetes |
508,270,707.60 |
| Under-construction Projects |
67,112,406.07 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
164,676,714.36 |
| R&D expenses |
1,291,793.37 |
| Goodwill |
301,018,847.02 |
| Long-Term Deferred and Prepaid Expenses |
2,686,882.51 |
| Deferred Income Tax Assets |
42,190,190.64 |
| Other Non-Current Assets |
34,842,717.84 |
| Sub-Total of Non-Current Assets |
1,179,298,930.13 |
| Total Assets |
3,823,025,304.55 |
| Short-Term Loans |
616,125,323.01 |
| Trading Financial liabilities |
-- |
| Notes Payable |
198,197,478.00 |
| Accounts Payable |
257,982,309.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,634,309.75 |
| Taxes Payable |
40,639,227.93 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
36,963,268.52 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,879,230.37 |
| Other Current Liabilities |
3,607,392.17 |
| Sub-Total of Current Liabilities |
1,179,303,717.10 |
| Long-term Loans |
248,710,678.70 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
4,059,198.16 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,050,059.30 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
271,884,113.55 |
| Total Liabilities |
1,451,187,830.65 |
| Paid-In Capital(Or Share Stock) |
420,090,164.00 |
| Capital Surplus |
1,121,441,489.79 |
| Surplus Reserve |
79,778,491.24 |
| LESS:Treasury Stock |
32,954,249.48 |
| Undistributed Profits |
596,696,701.49 |
| Minority Stockholder's Interest |
195,758,432.37 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,176,079,041.53 |
| Owner's Equity（Stockholder's Equity） |
2,371,837,473.90 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,823,025,304.55 |
